Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK
This document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). The aim is to support but not define EU policy on COVID-19 vaccination.
Fourth external quality assessment on species identification and antimicrobial susceptibility testing of Campylobacter, 2018
This report presents the results of the fourth round of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter (Campylobacter EQA4-AST) within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net). The objectives of this EQA4-AST were to determine the accuracy of quantitative AST results reported by participants; to identify common laboratory problems related to the guidance in the EU protocol, and to assess the overall comparability of routinely collected AST data from national public health reference laboratories across Europe.
Rapid Risk Assessment: Increased transmission of COVID-19 in the EU/EEA and the UK – thirteenth update
In this update, we assess the risk for the general population and vulnerable individuals in relation to the increase in COVID-19 notification rates in the EU/EEA and the UK.
Communicable disease threats report, 18-24 October 2020, week 43
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 October 2020 and includes updates on COVID-19 associated with SARS-CoV-2, influenza, West Nile virus, chikungunya, dengue, Ebola virus disease - eleventh outbreak in the Democratic Republic of the Congo.
Rapid outbreak assessment: Multi-country outbreak of Salmonella Typhimurium and S. Anatum infections linked to Brazil nuts
Since 1 August 2019, a multi-country outbreak, caused by Salmonella Typhimurium ST19 and S. Anatum ST64, has affected three European Union (EU) countries, the United Kingdom and Canada.
COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update
This document provides guidance on infection prevention and control (IPC) measures to healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) in order to prevent COVID-19 infection.
Influenza virus characterisation - Summary Europe, September 2020
This is the 10th and final report for the 2019–2020 influenza season. As of week 39/2020, 164 917 influenza detections across the WHO European Region had been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 480 (98%) of 4 569 ascribed to a lineage being B/Victoria.
Guidance for discharge and ending of isolation of people with COVID-19
This document provides guidance for planning the discharge and ending of isolation of COVID-19 patients.
Operational considerations for influenza surveillance in the WHO European Region during COVID-19: interim guidance
This document outlines operational considerations for how to support the continuity of national influenza surveillance systems and public health laboratories for the epidemiological and virological surveillance for influenza in the 2020–2021 season during the ongoing COVID-19 pandemic.
Communicable disease threats report, 11-17 October 2020, week 42
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11-17 October 2020 and includes updates on COVID-19 associated with SARS-CoV-2, malaria, West Nile virus, influenza, Ebola virus disease - eleventh outbreak in the Democratic Republic of the Congo and Poliomyelitis.